SEARCH

SEARCH BY CITATION

References

  • 1
    Seino Y, Nanjo K, Tajima N, et al. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Jpn Diabetes Soc 2010; 53: 450467 (Japanese).
  • 2
    Kuzuya N, Abe M, Ueda H, et al. Report of the committee on the diagnostic criteria of the oral glucose tolerance test for diabetes mellitus. J Jpn Diabetes Soc 1970; 13: 17 (Japanese).
  • 3
    Kosaka K, Akanuma Y, Goto Y, et al. Report of the committee on the diagnosis of diabetes mellitus. J Jpn Diabetes Soc 1982; 25: 859866. (Japanese); The essence of this report appears in English; Diab Res Clin Pract 1994; 24 (Suppl.): S59–S62.
  • 4
    Kuzuya T, Nakagawa S, Satoh J, et al. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. J Jpn Diabetes Soc 1999; 42: 385404. (Japanese); This report appears in English; Diabetes Res Clin Pract 2002; 55: 65–85.
  • 5
    Kadowaki T, Haneda M, Tominaga M, et al. Report of the Japan Diabetes Society’s Committee on the Diagnostic Criteria for Diabetes Mellitus and Glucose Metabolism Disorder—A New Category of Fasting Plasma Glucose Values: “high-normal”. J Jpn Diabetes Soc 2008; 51: 281283 (Japanese).
  • 6
    National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 10391057.
  • 7
    WHO Expert Committee on Diabetes Mellitus. Second report. World Health Organ Tech Rep Ser 1980; 646: 180.
  • 8
    The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 11831197.
  • 9
    Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539553.
  • 10
    Genuth S, Alberti KG, Bennett P, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 31603167.
  • 11
    World Health Organization. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO/IDF Consultation. World Health Org, 2006.
  • 12
    Shima K, Endo J, Oimomi M, et al. Interlaboratory difference in HbA1c measurement in Japan—the interim report of the committee on an interlaboratory standardization of HbA1c determination. J Jpn Diabetes Soc 1994; 37: 855864 (Japanese).
  • 13
    International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009; 32: 13271334.
  • 14
    American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33(Suppl 1): S62S69.
  • 15
    Kashiwagi A, Kadowaki T, Haneda M, et al. Consensus and Statement on International Standardization of HbA1C in Japan: Committee Report on Diabetes Mellitus Laboratory Testing Standardization. J Jpn Diabetes Soc 2009; 52: 811818 (Japanese).
  • 16
    Imagawa A, Hanafusa T, Miyagawa J, et al. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group. N Engl J Med 2000; 342: 301307.
  • 17
    Imagawa A, Hanafusa T, Uchigata Y, et al. Fulminant type 1 diabetes: a nationwide survey in Japan. Diabetes Care 2003; 26: 23452352.
  • 18
    Imagawa A. Discovery and establishment of fulminant type 1 diabetes mellitus and new classification of type 1 diabetes mellitus based on it. J Jpn Diabetes Soc 2004; 47: 796797 (Japanese).
  • 19
    Kobayashi T, Sato Y, Akazawa S. The position of type 1 in the classification of diabetes mellitus. J Jpn Diabetes Soc 1998; 41: A11A13 (Japanese).
  • 20
    Kobayashi T. Slowly Progressive IDDM. In: Japan Diabetes Society (ed). Advances in Diabetes Study, Volume 30. Shindan to Chiryosha, Tokyo, 1996 (Japanese).
  • 21
    Yasuda K, Miyake K, Horikawa Y, et al. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat Genet 2008; 40: 10921097.
  • 22
    Unoki H, Takahashi A, Kawaguchi T, et al. SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat Genet 2008; 40: 10981102.
  • 23
    Kitagawa T, Owada M, Urakami T, et al. Increased incidence of non-insulin dependent diabetes mellitus among Japanese schoolchildren correlates with an increased intake of animal protein and fat. Clin Pediatr (Phila) 1998; 37: 111115.
  • 24
    Fajans SS. Scope and heterogeneous nature of MODY. Diabetes Care 1990; 13: 4964.
  • 25
    Froguel P, Vaxillaire M, Velho G. Genetic and metabolic heterogeneity of maturity-onset diabetes of the young. Diabetes Rev 1997; 5: 123130.
  • 26
    Maassen JA, Kadowaki T. Maternally inherited diabetes and deafness: a new diabetes subtype. Diabetologia 1996; 39: 375382.
  • 27
    Sakagashira S, Sanke T, Hanabusa T, et al. Missense mutation of amylin gene (S20G) in Japanese NIDDM patients. Diabetes 1996; 45: 12791281.
  • 28
    Kasuga M, Kadowaki T. Insulin receptor disorders in Japan. Diabetes Res Clin Pract 1994; 24(Suppl): S145S151.
  • 29
    Nanjo K, Oka Y, Kadowaki T, et al. Recent aspects on diabetes mellitus associated with gene mutation in Japan. J Jpn Diabetes Soc 1998; 41: A29A31 (Japanese).
  • 30
    Malecki MT, Jhala US, Antonellis A, et al. Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nat Genet 1999; 23: 323328.
  • 31
    Gloyn AL, Pearson ER, Antcliff JF, et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 2004; 350: 18381849.
  • 32
    Babenko AP, Polak M, Cave H, et al. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. N Engl J Med 2006; 355: 456466.
  • 33
    Ito C. Classification of fasting plasma glucose levels and HbA1c. Health screen (Ningen Dock) 2008; 22: 874877 (Japanese).
  • 34
    Tominaga M. Lifestyle habits as factors in developing diabetes mellitus – from results of Funagata research focused on prospective cohort study in Japan. J Jpn Diabetes Soc 2008; 51: 473475 (Japanese).
  • 35
    Kosaka K. Various parameters used for the diagnosis of diabetes and for the epidemiological investigation—their characteristics, their mutual relationship and their application. J Jpn Diabetes Soc 1998; 41: A101A105 (Japanese).
  • 36
    Sasaki A, Shimizu T, Hasegawa K. Study of diagnostic criteria for diabetes melliltus from a viewpoint of clinical epidemiology. In: KosakaK (ed). Diabetology 99. Shindan to Chiryo Sha, Tokyo, 1999; 97105 (Japanese).
  • 37
    Kosaka K, Hagura R, Kuzuya T, et al. Insulin secretory response of diabetics during the period of improvement of glucose tolerance to normal range. Diabetologia 1974; 10: 775782.
  • 38
    Seino Y, Kurahachi H, Goto Y, et al. Comparative insulinogenic effects of glucose, arginine and glucagon in patients with diabetes mellitus, endocrine disorders and liver disease. Acta Diabetol Lat 1975; 12: 8999.
  • 39
    Seino Y, Kurahachi H, Goto Y, et al. The insulinogenic index in secondary diabetes. Horm Metab Res 1975; 12: 107115.
  • 40
    Kosaka K, Hagura R, Kuzuya T. Insulin responses in equivocal and definite diabetes, with special reference to subjects who had mild glucose intolerance but later developed definite diabetes. Diabetes 1977; 26: 944952.
  • 41
    Metzger BE, Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 19912002.
  • 42
    IADPSG Consensus Panel. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010; 33: 676682.
  • 43
    Yamada K, Nonaka K. Diabetic ketoacidosis in young obese Japanese men. Diabetes Care 1996; 19: 671.
  • 44
    Ito C, Maeda R, Ishida S, et al. Importance of OGTT for diagnosing diabetes mellitus based on prevalence and incidence of retinopathy. Diabetes Res Clin Pract 2000; 49: 181186.
  • 45
    Ito C, Maeda R, Ishida S, et al. Correlation among fasting plasma glucose, two-hour plasma glucose levels in OGTT and HbA1c. Diabetes Res Clin Pract 2000; 50: 225230.
  • 46
    Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006. Diabetes Care 2010; 33: 562568.
  • 47
    Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010; 362: 800811.
  • 48
    Jeppsson JO, Kobold U, Barr J, et al. Approved IFCC reference method for the measurement of HbA1c in human blood. Clin Chem Lab Med 2002; 40: 7889.
  • 49
    Mosca A, Goodall I, Hoshino T, et al. Global standardization of glycated hemoglobin measurement: the position of the IFCC Working Group. Clin Chem Lab Med 2007; 45: 10771080.
  • 50
    Nordin G, Dybkaer R. Recommendation for term and measurement unit for “HbA1c”. Clin Chem Lab Med 2007; 45: 10811082.
  • 51
    Kuzuya T, Nakagawa S, Satoh J, et al. Answers by Council members of JDS to a questionnaire on the diagnostic criteria and classification of diabetes mellitus. J Jpn Diabetes Soc 1997; 40: 203210 (Japanese).
  • 52
    McCance DR, Hanson RL, Charles MA, et al. Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ 1994; 308: 13231328.
  • 53
    Ito C. OGTT criteria seen from the relation of fasting and 2-hPG and complications. J Jpn Diabetes Soc 1998; 41: A33A36 (Japanese).
  • 54
    Kosaka K. Progress in diabetology. Diagnosis of diabetes mellitus. Critical matters on the new diagnositic criteria in the 1997 ADA report and 1998 WHO report. Shindan to Chiryo 2002; 90: 851861 (Japanese).
  • 55
    DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group. Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. BMJ 1998; 317: 371375.